Microbiomics: Dimensions, Applications, and Translational Implications of Human and Environmental Microbiome Research (Translational and Applied Genomics)

Microbiomics: Dimensions, Applications, and Translational Implications of Human and Environmental Microbiome Research describes a new, holistic approach to microbiomics. International experts provide in-depth discussion of current research methods for studying human, environmental, viral and fungal microbiomes, as well as the implications of new discoveries for human health, nutrition, disease, cancer research, probiotics and in the food and agricultural industries. Distinct chapters covering culturomics and sub-microbiomes, such as the viriome and mycetobiome, provide an integrative framework for the expansion of microbiomics into new areas of application, as well as crosspollination between research areas.

Detailed case studies include the use of microbiomics to develop natural products with antimicrobial properties, microbiomic enhancements in food and beverage technology, microbes for bioprotection and biopreservation, microbial tools to reduce antibiotic resistance, and maintenance and cultivation of human microbial communities.

• Provides an integrated approach for realizing the potential of microbiomics across the life, environmental, food and agricultural sciences
• Includes thorough analysis of human, environmental, viral and mycetol microbiomes, as well as methods and technology for identifying microbiotes
• Features chapter contributions from international leaders in microbiomic methods, technology and applications

Dr. Manousos E. Kambouris serves as a Scientific Advisor for the Golden Helix Foundation, Craven House, London, UK, an international non-profit research organization aiming to advance research and education in the area of genomic and personalized medicine and as a Post Doc Researcher in the Laboratory of Pharmacogenomics and Individualized Therapy, Department of Pharmacy, University of Patras. Dr. Kambouris has long participated in different aspects and applications of microbiology, human genomics, biosecurity and cancer research. In his own work, he pursues an integrative approach to microbiomics, employing various -omics-driven approaches and realizing their application in human health, selective and personalized medicine, and panbiosurveillance among other areas. He has published widely in such peer-reviewed journals as OMICS-JIB, Hemoglobin, Medical Mycology, FEMS Immunology & Medical Microbiology, Public Health Genomics, and Future Microbiology.

Dr. Aristea Velegraki is Associate Professor of Mycology at the National Kapodistrian University of Athens, Athens, Greece. She is founder and curator of the Hellenic Collection for Pathogenic Fungi http://www.eccosite.org/ (UOA/HCPF under Greece), and specializes in aspects and applications of mycology, from clinical infectious disease to toxicology, with extensive applied experience in microbiomic identification and sequencing technologies. She has served as Vice President of the International Society of Human and Animal Mycology (ISHAM) from 2006 to 2012, and has published widely in peer reviewed journals as Medical Mycology, OMICS, Clinical Microbiology and Infection, PLOS pathogens, Journal of Investigative Dermatology, Journal of Clinical Microbiology, Environmental Microbiology, Natural Product Communications, Journal of Ethnopharmacology, Fungal Genetics and Biology, and the American Journal of Clinical Pathology.